Literature DB >> 30415126

Cortical atrophy pattern-based subtyping predicts prognosis of amnestic MCI: an individual-level analysis.

Hee Jin Kim1, Jong-Yun Park2, Sang Won Seo3, Young Hee Jung1, Yeshin Kim4, Hyemin Jang1, Sung Tae Kim5, Joon-Kyung Seong6, Duk L Na7.   

Abstract

We categorized patients with amnestic mild cognitive impairment (aMCI) based on cortical atrophy patterns and evaluated whether the prognosis differed across the subtypes. Furthermore, we developed a classifier that learns the cortical atrophy pattern and predicts subtypes at an individual level. A total of 662 patients with aMCI were clustered into 3 subtypes based on cortical atrophy patterns. Of these, 467 patients were followed up for more than 12 months, and the median follow-up duration was 43 months. To predict individual-level subtype, we used a machine learning-based classifier with a 10-fold cross-validation scheme. Patients with aMCI were clustered into 3 subtypes: medial temporal atrophy, minimal atrophy (Min), and parietotemporal atrophy (PT) subtypes. The PT subtype had higher prevalence of APOE ε4 carriers, amyloid PET positivity, and greater risk of dementia conversion than the Min subtype. The accuracy for binary classification was 89.3% (MT vs. Rest), 92.6% (PT vs. Rest), and 86.6% (Min vs. Rest). When we used ensemble model of 3 binary classifiers, the accuracy for predicting the aMCI subtype at an individual level was 89.6%. Patients with aMCI with the PT subtype were more likely to have underlying Alzheimer's disease pathology and showed the worst prognosis. Our classifier may be useful for predicting the prognosis of individual aMCI patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Classifier; Cortical atrophy pattern; Mild cognitive impairment

Mesh:

Substances:

Year:  2018        PMID: 30415126     DOI: 10.1016/j.neurobiolaging.2018.10.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  6 in total

1.  Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients.

Authors:  Hyemin Jang; Hee Jin Kim; Seongbeom Park; Yu Hyun Park; Yeongsim Choe; Hanna Cho; Chul Hyoung Lyoo; Uicheul Yoon; Jin San Lee; Yeshin Kim; Seung Joo Kim; Jun Pyo Kim; Young Hee Jung; Young Hoon Ryu; Jae Yong Choi; Seung Hwan Moon; Joon-Kyung Seong; Charles DeCarli; Michael W Weiner; Samuel N Lockhart; Soo Hyun Cho; Duk L Na; Sang Won Seo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-31       Impact factor: 9.236

Review 2.  Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods.

Authors:  Mohamad Habes; Michel J Grothe; Birkan Tunc; Corey McMillan; David A Wolk; Christos Davatzikos
Journal:  Biol Psychiatry       Date:  2020-01-31       Impact factor: 13.382

3.  Clinically Available Software for Automatic Brain Volumetry: Comparisons of Volume Measurements and Validation of Intermethod Reliability.

Authors:  Ji Young Lee; Se Won Oh; Mi Sun Chung; Ji Eun Park; Yeonsil Moon; Hong Jun Jeon; Won Jin Moon
Journal:  Korean J Radiol       Date:  2020-11-03       Impact factor: 3.500

Review 4.  Imaging Clinical Subtypes and Associated Brain Networks in Alzheimer's Disease.

Authors:  Karl Herholz
Journal:  Brain Sci       Date:  2022-01-23

Review 5.  Addressing heterogeneity (and homogeneity) in treatment mechanisms in depression and the potential to develop diagnostic and predictive biomarkers.

Authors:  Cynthia H Y Fu; Yong Fan; Christos Davatzikos
Journal:  Neuroimage Clin       Date:  2019-08-28       Impact factor: 4.881

Review 6.  Widespread Morphometric Abnormalities in Major Depression: Neuroplasticity and Potential for Biomarker Development.

Authors:  Cynthia H Y Fu; Yong Fan; Christos Davatzikos
Journal:  Neuroimaging Clin N Am       Date:  2019-11-08       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.